What the $63 Billion AbbVie Allergan Deal Says About the Drug Industry: Brainstorm Health

Good afternoon, readers. Let’s parse the big news out of the health care acquisitions world–AbbVie announced on Tuesday that it will buy Allergan in a deal valued at about $63 billion, a 45% premium on Allergan’s most recent closing stock price. The proposed M&A will be one of the largest health care mergers of the […]

What AbbVie’s $63 Billion Deal to Buy Allergan Says About the Drug Industry

AbbVie announced on Tuesday that it will buy Allergan in a deal valued at about $63 billion, a 45% premium on Allergan’s most recent closing stock price. The proposed M&A will be one of the largest health care mergers of the year and bring together a portfolio that includes AbbVie’s Humira, the world’s best-selling drug, […]